0
July 1986, Vol 140, No. 7 >
Article | July 1986

Sustained-Release Terbutaline vs Sustained-Release Theophylline in Young Patients With Asthma FREE

Janet R. Roberts, MD; Haresh I. Desai, MD; Catherine A. Gillespie, RN; F. Estelle R. Simons, MD
[+] Author Affiliations

Accepted for publication Feb 5, 1986.

Read before the American Academy of Allergy, New York, March 18, 1985.

Reprint requests to Children's Hospital of Winnipeg, 840 Sherbrooke St, Winnipeg, Manitoba, Canada R3A 1S1 (Dr Simons).


Am J Dis Child. 1986;140(7):650-654. doi:10.1001/archpedi.1986.02140210048023.
Text Size: A A A
Published online
Article
References
Comments

• Twenty patients with asthma (mean age, 10.9 ±2 years) entered a six-week, randomized, double-blind, crossover comparison of sustained-release (S-R) terbutaline sulfate (Bricanyl Durules) vs S-R theophylline (Theo-Dur). In each two-week study period each patient received S-R theophylline twice daily in doses previously adjusted to give serum theophylline concentrations in the range of 10 to 20 mg/L (56 to 111 μmol/L); or S-R terbutaline sulfate, 5 mg twice daily; or S-R terbutaline sulfate, 7.5 mg twice daily. All treatment regimens produced significant improvement in one or more pulmonary function test values compared with prestudy values. The incidence of acute asthma episodes were similar during each treatment regimen. No clinically significant differences occurred between the regimens for daily symptom scores, peak expiratory flow rates, or use of a terbutaline metereddose inhaler. At the end of the theophylline treatment period, the mean (±SD) theophylline level 12 to 14 hours after the last dose was 10.1± 3.3 mg/L (56±18 μmol/L); at the end of the terbutaline treatment periods, the mean trough terbutaline levels were 2.22 μg/L (9.9±4.4 nmol/L) (S-R terbutaline sulfate, 5 mg twice daily) and 3.07 μg/L (13.7± 5.4 nmol/L) (S-R terbutaline sulfate, 7.5 mg twice daily). Adverse effects, including tremor, occurred with similar frequency during all three drug regimens. Sustained-release formulations of theophylline and terbutaline, in the dosages studied, provided comparable control of asthma symptoms.

(AJDC 1986;140:650-654)

REFERENCES

1 +
Leegaard J, Fjulsrud S:  Terbutaline in children with asthma . Arch Dis Child 1973;;48: 229-232.
2 +
Blumberg MZ, Tinkelman DG, Ginchansky EJ, et al:  Terbutaline and ephedrine in asthmatic children . Pediatrics 1977;;60:14-19.
3 +
Michaelson ED, Silva GT, Forrest TR, et al:  Effects of oral terbutaline in children with bronchial asthma . J Allergy Clin Immunol 1978;;61: 365-369.
4 +
Ardal B, Beaudry P, Eisen AH:  Terbutaline in asthmatic children: A dose-response study . J Pediatr 1978;;93:305-308.
5 +
Simons FER, Pizey DM, Archer JW, et al:  Terbutaline elixir in preschool children with chronic asthma . Ann Allergy 1979;;43:275-278.
6 +
Manaligod LM, Gavani UD, Hyde JS, et al:  Safety and effectiveness of terbutaline in children with chronic asthma . Chest 1979;;76:532-535.
7 +
Haddad ZH, Stumbaugh S, Davis WR:  A comparison of the bronchodilator and other responses of children to oral treatment with terbutaline tablet and solution: A bioequivalence study . Ann Allergy 1980;;44:86-90.
8 +
Lonnerholm G, Foucard T, Lindstrom B:  Dose, plasma concentration, and effect of oral terbutaline in long-term treatment of childhood asthma . J Allergy Clin Immunol 1984;;73: 508-515.
9 +
Taudorf E, Bundgaard A, Fagerstrom PO, et al:  Terbutaline depot tablets in asthma . Allergy 1981;;36:495-500.
10 +
Eriksson NE, Haglind K, Ljungholm K:  A comparison of sustained-release terbutaline and ordinary terbutaline in bronchial asthma . Br J Dis Chest 1982;;76:202-204.
11 +
Wettrel G, in discussion, Nyberg L, Kennedy BM:  Pharmacokinetics of terbutaline given in slow-release tablets . Eur J Respir Dis 1984;; 65( (suppl 134) ):137-139.
12 +
Foged N, Host A, Ljungholm K:  Terbutaline depot tablets in childhood asthma . Allergy 1985;;40:497-500.
13 +
Bell T, Bigley J:  Sustained-release theophylline therapy for chronic childhood asthma . Pediatrics 1978;;62:352-358.
14 +
Kelly HW, Murphy S:  Efficacy of a 12-hour sustained-release preparation in maintaining therapeutic serum theophylline levels in asthmatic children . Pediatrics 1980;;66:97-102.
15 +
Scott PH, Tabachnik E, MacLeod S, et al:  Sustained-release theophylline for childhood asthma: Evidence for circadian variation of theophylline pharmacokinetics . J Pediatr 1981;;99: 476-479.
16 +
Simons FER, Luciuk GH, Simons KJ:  Sustained-release theophylline for treatment of asthma in preschool children . AJDC 1982;;136: 790-793.
17 +
Dickman ML, Schmidt CD, Gardner RM:  Spirometric standards for normal children and adolescents (ages 5 years through 18 years) . Am Rev Respir Dis 1971;;104:680-687.
18 +
Cherniack RM:  Ventilatory function in normal children . Can Med Assoc J 1962;;87:80-81.
19 +
Jacobsson S-E, Jonsson S, Lindberg C, et al:  Determination of terbutaline in plasma by gas chromatography chemical ionization mass spectrometry . Biomed Mass Spectrometry 1980;;7:265-268.
20 +
Simons KJ, Frith EM, Simons FER:  Dissolution and bioavailability studies of whole and halved sustained-release theophylline tablets . J Pharm Sci 1982;;71:505-511.
21 +
Feinstein AR: Clinical Biostatistics . St Louis, CV Mosby Co, 1977;.
22 +
Bengtsson B, Fagerstrom PO:  Extrapulmonary effects of terbutaline during prolonged administration . Clin Pharmacol Ther 1982;;31: 726-732.
23 +
Hultquist C, Lindberg C, Nyberg L, et al:  Kinetics of terbutaline in asthmatic children . Eur J Respir Dis 1984;;65( (suppl 134) ):195-203.
24 +
Nyberg L, Kennedy BM:  Pharmacokinetics of terbutaline given in slow-release tablets . Eur J Respir Dis 1984;;65( (suppl 134) ):119-137.
25 +
Billing B, Dahlqvist R, Garle M, et al:  Separate and combined use of terbutaline and theophylline in asthmatics . Eur J Respir Dis 1982;;63:399-409.
26 +
Wolfe JD, Tashkin DP, Calvarese B, et al:  Bronchodilator effects of terbutaline and aminophylline alone and in combination in asthmatic patients . N Engl J Med 1978;;298:363-367.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

1 +
Leegaard J, Fjulsrud S:  Terbutaline in children with asthma . Arch Dis Child 1973;;48: 229-232.
2 +
Blumberg MZ, Tinkelman DG, Ginchansky EJ, et al:  Terbutaline and ephedrine in asthmatic children . Pediatrics 1977;;60:14-19.
3 +
Michaelson ED, Silva GT, Forrest TR, et al:  Effects of oral terbutaline in children with bronchial asthma . J Allergy Clin Immunol 1978;;61: 365-369.
4 +
Ardal B, Beaudry P, Eisen AH:  Terbutaline in asthmatic children: A dose-response study . J Pediatr 1978;;93:305-308.
5 +
Simons FER, Pizey DM, Archer JW, et al:  Terbutaline elixir in preschool children with chronic asthma . Ann Allergy 1979;;43:275-278.
6 +
Manaligod LM, Gavani UD, Hyde JS, et al:  Safety and effectiveness of terbutaline in children with chronic asthma . Chest 1979;;76:532-535.
7 +
Haddad ZH, Stumbaugh S, Davis WR:  A comparison of the bronchodilator and other responses of children to oral treatment with terbutaline tablet and solution: A bioequivalence study . Ann Allergy 1980;;44:86-90.
8 +
Lonnerholm G, Foucard T, Lindstrom B:  Dose, plasma concentration, and effect of oral terbutaline in long-term treatment of childhood asthma . J Allergy Clin Immunol 1984;;73: 508-515.
9 +
Taudorf E, Bundgaard A, Fagerstrom PO, et al:  Terbutaline depot tablets in asthma . Allergy 1981;;36:495-500.
10 +
Eriksson NE, Haglind K, Ljungholm K:  A comparison of sustained-release terbutaline and ordinary terbutaline in bronchial asthma . Br J Dis Chest 1982;;76:202-204.
11 +
Wettrel G, in discussion, Nyberg L, Kennedy BM:  Pharmacokinetics of terbutaline given in slow-release tablets . Eur J Respir Dis 1984;; 65( (suppl 134) ):137-139.
12 +
Foged N, Host A, Ljungholm K:  Terbutaline depot tablets in childhood asthma . Allergy 1985;;40:497-500.
13 +
Bell T, Bigley J:  Sustained-release theophylline therapy for chronic childhood asthma . Pediatrics 1978;;62:352-358.
14 +
Kelly HW, Murphy S:  Efficacy of a 12-hour sustained-release preparation in maintaining therapeutic serum theophylline levels in asthmatic children . Pediatrics 1980;;66:97-102.
15 +
Scott PH, Tabachnik E, MacLeod S, et al:  Sustained-release theophylline for childhood asthma: Evidence for circadian variation of theophylline pharmacokinetics . J Pediatr 1981;;99: 476-479.
16 +
Simons FER, Luciuk GH, Simons KJ:  Sustained-release theophylline for treatment of asthma in preschool children . AJDC 1982;;136: 790-793.
17 +
Dickman ML, Schmidt CD, Gardner RM:  Spirometric standards for normal children and adolescents (ages 5 years through 18 years) . Am Rev Respir Dis 1971;;104:680-687.
18 +
Cherniack RM:  Ventilatory function in normal children . Can Med Assoc J 1962;;87:80-81.
19 +
Jacobsson S-E, Jonsson S, Lindberg C, et al:  Determination of terbutaline in plasma by gas chromatography chemical ionization mass spectrometry . Biomed Mass Spectrometry 1980;;7:265-268.
20 +
Simons KJ, Frith EM, Simons FER:  Dissolution and bioavailability studies of whole and halved sustained-release theophylline tablets . J Pharm Sci 1982;;71:505-511.
21 +
Feinstein AR: Clinical Biostatistics . St Louis, CV Mosby Co, 1977;.
22 +
Bengtsson B, Fagerstrom PO:  Extrapulmonary effects of terbutaline during prolonged administration . Clin Pharmacol Ther 1982;;31: 726-732.
23 +
Hultquist C, Lindberg C, Nyberg L, et al:  Kinetics of terbutaline in asthmatic children . Eur J Respir Dis 1984;;65( (suppl 134) ):195-203.
24 +
Nyberg L, Kennedy BM:  Pharmacokinetics of terbutaline given in slow-release tablets . Eur J Respir Dis 1984;;65( (suppl 134) ):119-137.
25 +
Billing B, Dahlqvist R, Garle M, et al:  Separate and combined use of terbutaline and theophylline in asthmatics . Eur J Respir Dis 1982;;63:399-409.
26 +
Wolfe JD, Tashkin DP, Calvarese B, et al:  Bronchodilator effects of terbutaline and aminophylline alone and in combination in asthmatic patients . N Engl J Med 1978;;298:363-367.

Correspondence

Submit a Letter
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Clear Answers | Save For Later
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general journals
BMJ 2010;341:c5893-c1494.
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems